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Abstract: The unstrained S-allyl cysteine amino acid was site-
specifically installed on apoptosis protein biomarkers and was
further used as a chemical handle and ligation partner for
1,2,4,5-tetrazines by means of an inverse-electron-demand
Diels–Alder reaction. We demonstrate the utility of this
minimal handle for the efficient labeling of apoptotic cells
using a fluorogenic tetrazine dye in a pre-targeting approach.
The small size, easy chemical installation, and selective
reactivity of the S-allyl handle towards tetrazines should be
readily extendable to other proteins and biomolecules, which
could facilitate their labeling within live cells.
The inverse-electron-demand Diels–Alder reaction
(IEDDA) between tetrazines and alkenes have recently
found widespread application as an alternative “click”
reaction for chemical biology applications due to its high
chemoselectivity, fast reaction kinetics, and metal-free
nature.[1] Most protein-labeling approaches through IEDDA
ligation rely on strained cyclic alkenes and alkynes, such as
norbornene,[2] trans-cyclooctene (TCO),[3] or bicyclo-
[6.1.0]nonyne,[3b] that are introduced on proteins by genetic
encoding methods for subsequent reaction with tetrazines.
Alternatively, tetrazines may also be genetically encoded into
proteins and subsequently labeled with TCO.[4] While these
strained coupling partners reach very fast reaction kinetics
with tetrazines (k2 up to 10
4m@1 s@1),[5] their metabolic stability
and potential cross-reactivity with biological nucleophiles is
still arguable.[6] In addition, their large size can potentially
impact the protein structure, activity, or localization. Thus,
there is a requirement for the development of reactive, yet
stable and sterically small, alkene-handles for tetrazine
IEDDA labeling approaches.[7] In one example, a small-
sized methylcyclopropene tag reacted with high selectivity
and relative fast kinetics with tetrazines (k2& 0.1–3m@1 s@1).[8]
More recently, genetically encoded fatty acylated lysine (Lys)
derivatives bearing unstrained alkenes were used to reveal
Sirt6-targeted histone H3 sites in nucleosomes upon reaction
with tetrazines.[9]
The abovementioned approaches rely on genetic encoding
of Lys derivatives bearing a reactive dienophile moiety.
Instead, we thought to explore cysteine (Cys) as a site for the
chemical installation of the dienophile counterpart. We chose
S-allyl as an unstrained, small-sized alkene handle for
reaction with tetrazines. The S-allyl handle, when chemically
installed on a surface-exposed Cys on a protein or peptides,
has proven to be an efficient partner for ruthenium-catalyzed
cross-metathesis.[10] The future development of genetic strat-
egies to site-specifically encode S-allyl Cys, which is stable in
the presence of biological thiols and is non-toxic to cells up to
1 mm (HeLa and HepG2 cells, see the Supporting Informa-
tion), may also potentiate their use in bioorthogonal labeling
strategies.[10b]
Herein, we have explored S-allyl Cys as a coupling amino
acid partner for IEDDA reactions that proved to be reactive
toward tetrazines with reasonable reaction kinetics (k2
& 0.002m@1 s@1). We demonstrated that S-allyl Cys could be
easily chemically installed into apoptosis protein biomarkers
that specifically recognize the externalized phosphatidylser-
ine (PS) membrane lipid through a [2,3]-sigmatropic rear-
rangement with allyl selenocyanate.[11] Using a pre-targeting
approach, and upon reaction with a fluorogenic tetrazine,
efficient live-imaging of apoptotic cells was achieved. The
easy chemical installation of the S-allyl handle and avail-
ability of protein and antibody biomarkers, which have
already been engineered with a free Cys residue, combined
with the specificity and favorable kinetics of the IEDDA
reaction, makes this a readily adoptable labeling strategy for
pre-targeting approaches.[12]
We started our study by investigating the reactivity of the
unstrained alkene handle in IEDDA reactions using S-allyl
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Cys amino acid 1 as a model (Figure 1a,b). Reaction kinetics
between 1 and tetrazines PyTz 2, BnNH2-Tz 3, Tz-Rhod 4,
and Tz-Cy3 5 were determined in phosphate-buffered saline
(PBS) pH 7.4/methanol (1:1) at 37 8C (Figure 1b–d). The
pyridine–tetrazine and benzylamine–tetrazine cores were
selected due to their high reactivity in Diels–Alder reactions
and high in vitro stability.[13] This model amino acid 1 and
tetrazine Tz-Rhod 4 were synthesized as described in the
Supporting Information. Kinetic studies were carried out
under pseudo-first-order conditions in which the alkene
concentration was at least 375-fold higher than the concen-
tration of the tetrazines. The determined second-order
reaction rate constants are presented in Figure 1e. For the
tetrazine cores 2 and 3, the reactions were monitored by
following the decrease of the tetrazine absorbance at 320 nm
(Figure 1 f). As shown in Figure 1, Py-Tz 2 exhibited a slightly
higher rate constant (k2= 2.05X 10
@3m@1 s@1) than BnNH2-Tz
3 (k2= 0.54X 10
@3m@1 s@1). These values are lower than those
reported for strained alkenes,[5] but are directly comparable to
those of, for example, strain-promoted azide–alkyne cyclo-
addition “SPAAC” (k2& 10@3–10@1m@1 s@1) that is widely used
for cellular labeling purposes.[5, 14] To demonstrate that the
tetrazine-dye probes Tz-Rhod 4 and Tz-Cy3 5 also react
efficiently with 1, their kinetics were also evaluated. In this
case, conjugation of rhodamine and Cy3 moieties to the
tetrazine cores results in fluorescence quenching. Cycloaddi-
tion of the tetrazine moieties and the alkene abolishes this
intrinsic quenching effect, leading to an increased “turn-on”
of the fluorescence signal that could be readily detected by
fluorimetry (Figure 1g). The obtained rate constants calcu-
lated for these reactions (k2= 0.34X 10
@3 m@1 s@1 for 1:Tz-
Rhod 4 ; k2= 0.26X 10
@3m@1 s@1 for 1:Tz-Cy3 5) are identical
compared to the corresponding tetrazine cores. The smaller
reactivity difference found for Tz-Rhod 4 and Tz-Cy3 5 may
be attributed to structural differences of the fluorophores.
Kinetics studies for the reaction between 5-norbornen-2-ol
and Tz-Cy3 5 showed that the norbornene/tetrazine ligation
(k2& 0.21m@1 s@1) is & 800 times faster than the S-allyl Cys/
tetrazine ligation (Supporting Information). Similar reaction
rates for comparable norbornene/tetrazine coupling partners
have been reported.[15] The fluorogenicity of the tetrazine-
dyes was also studied. It was observed that, upon cyclo-
addition, the fluorescence of 4 and 5 is enhanced by 5- and 2.5-
fold, respectively (Supporting Information).
Encouraged by the kinetic analysis, we proceeded to
synthesize proteins incorporating an S-allyl handle for
IEDDA labeling. As model proteins, we chose Annexin V
(AnxV)[16] and an engineered variant of the C2A domain of
Synaptotagmin-I (C2Am),[17] two apoptosis-specific biomark-
ers, that contain a free Cys residue. Because there are no
other free Cys residues on these proteins, this provides
a unique site for their site-specific modification. The S-allyl
handle was installed on Cys through a [2,3]-sigmatropicFigure 1. a) General reaction showing the application of IEDDA reac-
tions for protein labeling with a site-specifically installed S-allyl handle.
b–d) Structures of S-allyl Cys, tetrazine cores, and fluorophores used in
this study. e) Rate constants for the reaction of 2–5 with the model
amino acid S-allyl Cys 1 were measured following the consumption of
tetrazines by UV/Vis (f) or fluorescence (g).
Figure 2. Chemical approach used for protein labeling through IEDDA
reaction between S-allyl Cys-tagged proteins and tetrazines. a) The
unstrained alkene handle was site-specifically installed into AnxV by
allylation of Cys315 through a [2,3]-sigmatropic rearrangement with
allyl selenocyanate. A tetrazine probe could selectively react with the
installed alkene. b) Deconvoluted ESI-MS spectrum of AnxV S-allyl Cys.
c) Deconvoluted ESI-MS spectrum of the product of the reaction
between AnxV S-allyl Cys and PyTz 2. d) Deconvoluted ESI-MS spec-
trum of the product of the reaction between AnxV S-allyl Cys and
BnNH2-Tz 3. e) MS/MS spectrum of the m/z 652.12 doubly charged
ion of the Cys-modified peptide KALLLLCGEDD from AnxV. The
underscore relates to the modified amino acid.
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rearrangement using allyl selenocyanate after 1 h at room
temperature (Figure 2a,b).[10c] Direct allylation with allyl
chloride was less efficient, with complete conversion to the
product observed only after 3 h at 37 8C and using pH 11 (at
pH 8 no product was detected; Supporting Information). It
was also observed that these conditions resulted in significant
protein loss (through degradation or precipitation) when
compared to the allyl selenocyanate reaction (mass yields of
91% and 48% for allyl selenocyanate and allyl chloride
reactions, respectively, as assessed by Bradford protein assay).
S-allyl-tagged AnxV was then subjected to reaction with
tetrazine cores Py-Tz 2 and BnNH2-Tz 3 (Figure 2c,e).
Product formation was detected (& 40% conversion) by
LC-ESI-MS after 20 and 12 h of reaction, respectively
(complete reaction was obtained after 96 h for 2 and 36 h
for 3 ; Supporting Information). Reactions were monitored
using Liquid Chromatography-Electrospray Ionization Mass
Spectrometry (LC-ESI-MS) analysis and EllmanQs test (data
for C2Am shown in the Supporting Information).
LC-ESI-MS analysis of the reactions with both tetrazine
cores revealed that, besides the desired product, there was
also the formation of a secondary product (10–20%) corre-
sponding to the addition of two tetrazine moieties to the
proteins (identical results were obtained for both AnxV and
C2Am; Figure 2b,c and Supporting Information). Cross-
reactivity of reagents with other amino acids is a major
issue for the efficiency of bioorthogonal labeling. For
instance, it was recently reported that 2,5-diaryltetrazoles,
which were thought to selectively react with alkenes through
light-induced 1,3-dipolar cycloadditions,[18] also react with
native tryptophan (Trp) residues on proteins.[19] To verify
whether the observed addition of two tetrazine moieties was
the result of cross-reactivity with other unsaturated canonical
amino acids, tetrazine 2 was reacted with native proteins
AnxV and C2Am (that is, without the S-allyl handle) under
the same IEDDA reaction conditions (200 equivalents of
tetrazine, 37 8C for 96 h). These control experiments revealed
that there is no addition of 2 to either AnxV or C2Am when
the S-allyl handle is not present (Supporting Information).
Importantly, we showed that Trp and histidine (His), both
possessing potentially reactive double bonds, do not react
with 2 even under forcing conditions (Supporting Informa-
tion). Moreover, the specificity of the IEDDA reaction
towards the S-allyl handle was further demonstrated by
replacing it by dimethylallyl or propargyl groups that also
gave no addition reaction in the presence of a tetrazine
(Supporting Information). Finally, the Boc- and methyl ester-
protected S-allyl Cys amino acid model was reacted with Py-
Tz 2 yielding the corresponding reduced and oxidized
dihydropyridazine and pyridazine species, as well as a third
compound resulting from the addition of a second tetrazine
moiety to one of the pyridazine species (Supporting Informa-
tion). These data on small molecules are consistent with our
experiments on the protein context, which demonstrate that
the formation of the bis-adduct is not a result of cross
reactivity with canonical amino acids but instead is the
product of the reaction of a second tetrazine moiety with the
first one. A detailed computational study and discussion of
the whole reaction profile at the PCM(H2O)/M06-2X/6-
31G(d) level of theory using complete models for both the
amino acid and tetrazine counterparts is available in the
Supporting Information (Figures S40–42).
To confirm the site of the modification, the protein
conjugates were subjected to tryptic digestion, and the
resulting peptide fragments were analyzed by LC-MS/MS.
This showed that modification with Py-Tz 2 occurs at Cys315
where the S-allyl handle has been chemically installed
(Figure 2d; results for C2Am are shown in the Supporting
Information). Labeling of AnxV S-allyl Cys with the tetrazine
fluorophores Tz-Rhod 4 and Tz-Cy3 5 was also studied. The
reactions were set up in PBS buffer at pH 7.6 with 10%DMF
in the presence of 200 equivalents of tetrazine dyes 4 and 5.
The labeling of AnxV was confirmed by SDS-PAGE (Fig-
Figure 3. a) Pre-targeting of apoptotic cells with AnxV S-allyl Cys
followed by IEDDA labeling with fluorogenic Tz-Cy3 5. b) SDS-PAGE of
AnxV labeled with Tz-Rhod 4 and Tz-Cy3 5 for 12 h at 37 8C. The
labeled protein was purified by dialysis. Left image shows Coomassie
blue-stained gels and the right image presents the fluorescent imaging
of the same gels before staining with Coomassie blue. c) ESI-MS
spectrum of the product of the reaction of AnxV S-allyl Cys with Tz-Cy3
5. d) Specific labeling of apoptotic cells (ii) pre-targeted with AnxV S-
allyl Cys and subsequently labeled with Tz-Cy3 5. Cells were imaged 3 h
after addition of the fluorogenic dye 5. Non-apoptotic cells (i) were
included as a control. The specificity of the labeling was confirmed
through blocking of cells with non-labeled AnxV (iii) prior to incubation
with AnxV S-allyl Cys or by treating cells only with the tetrazine probe
Tz-Cy3 5 (iv) without preincubation with the targeting protein AnxV S-
allyl Cys. Apoptotic cells are shown red, while the nuclei counter-
stained with Hoechst 33342 are shown blue. Scale bar=100 mm.
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ure 3b) and LC-ESI-MS (Figure 3c) analysis. Fluorescence
imaging of the gel showed a band corresponding to the
fluorescently labeled protein (Figure 3b), while LC-ESI-MS
indicated 40% conversion to the product of the reaction with
5 after 12 h at 37 8C. For LC-ESI-MS analysis of the reaction
with 4, see the Supporting Information.
Having successfully demonstrated the tetrazine reaction
with unstrained alkenes chemically installed on specific Cys
residues in recombinant proteins in vitro, we then proceeded
to test our strategy for live imaging using a cell model of
apoptosis. Because we noticed some fluorescence background
when using Tz-Rhod 4 (Figure S36), we decided to use Tz-
Cy3 5 dye in these studies. Dye 5 has greater aqueous
solubility and a very low fluorescence background. Remark-
ably, with this tetrazine the S-allyl Cys-tagged AnxV protein
was efficiently labeled, enabling visualization of apoptotic
cells in a pre-targeting approach (Figure 3a). In particular,
apoptotic HEK293 cells induced with actinomycin D were
incubated with AnxV S-allyl Cys for 45 min at 37 8C. After
this preincubation step, the growth media was replaced to
remove unbound protein and then treated with Tz-Cy3 5 for
3 h. After washing, the cells were imaged using both Tritc and
Hoechst fluorescence channels (Figure 3d). Significant label-
ing was observed (Figure 3d ii) compared to non-apoptotic
cells (Figure 3d i). Cells previously blocked with non-labelled
AnxV to block the externalized membrane lipid phosphati-
dylserine (PS) on the cell surface of apoptotic cells showed no
labeling after exposure to AnxV S-allyl Cys and subsequent
reaction with Tz-Cy3 5 (Figure 3d iii). A final control was
performed where cells were treated only with tetrazine probe
Tz-Cy3 5 without preincubation with the targeting protein
AnxV S-allyl Cys. Once again, apoptotic cells did not display
any fluorescence (Figure 3d iv). We also found that after 2 h
apoptotic cells already display strong fluorescence (Fig-
ure S37), however, longer reaction times (3 h) results in
higher contrast. Overall, these studies demonstrate the
specificity of the tetrazine imaging probe for S-allyl Cys
AnxV in the presence of live cells and growth media.
Additionally, our data show that protein-specific activity is
retained after the bioorthogonal IEDDA labeling in cells.
In summary, we demonstrate that unstrained S-allyl
handles precisely installed at predefined Cys residues within
the sequence of a protein are suitable chemical handles for
IEDDA reactions with tetrazine dyes. This strategy allowed
for selective labeling of proteins in live cells using a pre-
targeting approach. The easy site-specific installation and the
small size of the allyl handle, which is potentially less
disruptive compared to non-canonical amino acids bearing
bulky strained alkenes, is likely to be of a general benefit for
other sensitive protein systems including antibodies used in
pre-targeting approaches. As such, we believe that the simple
site-specific labeling strategy disclosed here, which enables
bioorthogonal live-cell imaging, will find significant use in the
biological community, allowing imaging of specific targets
with minimal effects on their intrinsic properties.[20]
Experimental Section
Synthetic procedures and kinetic studies are described in detail in
the Supporting Information. Protein labeling through S-allyl:tetra-
zine cycloaddition: S-allyl handle was installed on AnxV by reaction
with allyl selenocyanate (100 equivalents) for 1 h at room temper-
ature. Labeling of AnxV S-allyl Cys with the tetrazine fluorophores
Tz-Rhod 4 and Tz-Cy3 5 (5–12 h at 37 8C) was assessed by SDS-
PAGE and LC-ESI-MS analysis as described in the Supporting
Information. For cell labeling and imaging, HEK293 cells were grown
on coverslips and treated with 2 mm of actinomycin D for 12 h at 37 8C.
After induction of apoptosis, cells were incubated with AnxV S-allyl
Cys in fresh media for 45 min at 37 8C (0.62 mm). Cells were then
washed with d-PBS before incubating for 1, 2, and 3 h with the
tetrazine fluorophores 4 or 5 (375 mm), which were diluted in fresh
growth media. Blocking studies were performed by preincubating
apoptotic cells for 30 min with a 10x excess of non-fluorescent AnxV
(6.30 mm) before incubation with AnxV S-allyl Cys. To test binding
specificity (control), cells were treated with Tz-Cy3 5 without
preincubation with AnxV S-allyl Cys. After labeling, cells were
washed 2x with PBS, fixed with PBS containing 4% (w/v) formalde-
hyde, and finally imaged by fluorescence microscopy.
Acknowledgements
We thank China Scholarship Council (PhD studentship to
Z.G.), FCT Portugal (FCT Investigator to G.J.L.B.), and the
EU (Marie-Sklodowska Curie ITN Protein Conjugates ;
Marie-Sklodowska Curie IEF to B.L.O. and O.B.),
MINECO (CTQ2015-70524-R and RYC-2013-14706 to
G.J.O.), and the EPSRC for funding. We also thank Dr.
Andr8 Neves and Prof. Kevin Brindle for providing the
C2Am protein; Beatrice Amgarten for expressing and
purifying Annexin V; Dr. Mike Deery and Ms. Julie
Howard for help with mass spectrometry analysis; and BiFi
(Memento cluster) for computer support. G.J.L.B. is a Royal
Society University Research Fellow and the recipient of
a European Research Council Starting Grant (TagIt).
Keywords: apoptosis · bioorthogonal labeling · Diels–
Alder reactions · pre-targeting · unstrained alkenes
How to cite: Angew. Chem. Int. Ed. 2016, 55, 14683–14687
Angew. Chem. 2016, 128, 14903–14907
[1] a) D. M. Patterson, L. A. Nazarova, J. A. Prescher, ACS Chem.
Biol. 2014, 9, 592 – 605; b) K. Lang, J. W. Chin, Chem. Rev. 2014,
114, 4764 – 4806.
[2] a) N. K. Devaraj, R.Weissleder, S. A. Hilderbrand,Bioconjugate
Chem. 2008, 19, 2297 – 2299; b) K. Lang, L. Davis, J. Torres-
Kolbus, C. Chou, A. Deiters, J. W. Chin,Nat. Chem. 2012, 4, 298 –
304; c) E. Kaya, M. Vrabel, C. Deiml, S. Prill, V. S. Fluxa, T.
Carell, Angew. Chem. Int. Ed. 2012, 51, 4466 – 4469; Angew.
Chem. 2012, 124, 4542 – 4545.
[3] a) M. L. Blackman, M. Royzen, J. M. Fox, J. Am. Chem. Soc.
2008, 130, 13518 – 13519; b) K. Lang, L. Davis, S. Wallace, M.
Mahesh, D. J. Cox, M. L. Blackman, J. M. Fox, J. W. Chin, J. Am.
Chem. Soc. 2012, 134, 10317 – 10320; c) A. Darko, S. Wallace, O.
Dmitrenko, M. M. Machovina, R. A. Mehl, J. W. Chin, J. M. Fox,
Chem. Sci. 2014, 5, 3770 – 3776.
[4] a) J. L. Seitchik, J. C. Peeler, M. T. Taylor, M. L. Blackman, T. W.
Rhoads, R. B. Cooley, C. Refakis, J. M. Fox, R. A. Mehl, J. Am.
Chem. Soc. 2012, 134, 2898 – 2901; b) R. J. Blizzard, D. R.
Angewandte
ChemieCommunications
14686 www.angewandte.org T 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2016, 55, 14683 –14687
Backus, W. Brown, C. G. Bazewicz, Y. Li, R. A. Mehl, J. Am.
Chem. Soc. 2015, 137, 10044 – 10047.
[5] K. Lang, J. W. Chin, ACS Chem. Biol. 2014, 9, 16 – 20.
[6] R. Rossin, S. M. van den Bosch, W. ten Hoeve, M. Carvelli,
R. M. Versteegen, J. Lub, M. S. Robillard, Bioconjugate Chem.
2013, 24, 1210 – 1217.
[7] H. Wu, N. K. Devaraj, Top. Curr. Chem. 2015, 374, 1 – 22.
[8] a) J. Yang, J. Sˇecˇkute˙, C. M. Cole, N. K. Devaraj, Angew. Chem.
Int. Ed. 2012, 51, 7476 – 7479; Angew. Chem. 2012, 124, 7594 –
7597; b) J. Yang, Y. Liang, J. Sˇecˇkute˙, K. N. Houk, N. K. Devaraj,
Chem. Eur. J. 2014, 20, 3365 – 3375; c) D. M. Patterson, L. A.
Nazarova, B. Xie, D. N. Kamber, J. A. Prescher, J. Am. Chem.
Soc. 2012, 134, 18638 – 18643; d) D. N. Kamber, L. A. Nazarova,
Y. Liang, S. A. Lopez, D. M. Patterson, H.-W. Shih, K. N. Houk,
J. A. Prescher, J. Am. Chem. Soc. 2013, 135, 13680 – 13683.
[9] a) W. W. Wang, Y. Zeng, B. Wu, A. Deiters, W. R. Liu, ACS
Chem. Biol. 2016, 11, 1973 – 1981; b) Y.-J. Lee, Y. Kurra, Y. Yang,
J. Torres-Kolbus, A. Deiters, W. R. Liu, Chem. Commun. 2014,
50, 13085 – 13088.
[10] a) Y. A. Lin, J. M. Chalker, N. Floyd, G. J. L. Bernardes, B. G.
Davis, J. Am. Chem. Soc. 2008, 130, 9642 – 9643; b) Y. A. Lin,
J. M. Chalker, B. G. Davis, J. Am. Chem. Soc. 2010, 132, 16805 –
16811; c) J. M. Chalker, Y. A. Lin, O. Boutureira, B. G. Davis,
Chem. Commun. 2009, 3714 – 3716; d) J. M. Chalker, Aust. J.
Chem. 2015, 68, 1801 – 1809, and references therein.
[11] a) D. Crich, V. Krishnamurthy, T. K. Hutton, J. Am. Chem. Soc.
2006, 128, 2544 – 2545; b) D. Crich, V. Krishnamurthy, F.
Brebion, M. Karatholuvhu, V. Subramanian, T. K. Hutton, J.
Am. Chem. Soc. 2007, 129, 10282 – 10294.
[12] N. K. Devaraj, R. Weissleder, Acc. Chem. Res. 2011, 44, 816 –
827.
[13] M. R. Karver, R. Weissleder, S. A. Hilderbrand, Bioconjugate
Chem. 2011, 22, 2263 – 2270.
[14] J. M. Baskin, J. A. Prescher, S. T. Laughlin, N. J. Agard, P. V.
Chang, I. A. Miller, A. Lo, J. A. Codelli, C. R. Bertozzi, Proc.
Natl. Acad. Sci. USA 2007, 104, 16793 – 16797.
[15] a) M. Vrabel, P. Kçlle, K. M. Brunner, M. J. Gattner, V. Llpez-
Carrillo, R. de Vivie-Riedle, T. Carell, Chem. Eur. J. 2013, 19,
13309 – 13312; b) A.-C. Knall, M. Hollauf, C. Slugovc, Tetrahe-
dron Lett. 2014, 55, 4763 – 4766.
[16] S. E. Logue, M. Elgendy, S. J. Martin,Nat. Protoc. 2009, 4, 1383 –
1395.
[17] I. S. Alam, A. A. Neves, T. H. Witney, J. Boren, K. M. Brindle,
Bioconjugate Chem. 2010, 21, 884 – 891.
[18] W. Song, Y. Wang, J. Qu, M. M. Madden, Q. Lin, Angew. Chem.
Int. Ed. 2008, 47, 2832 – 2835; Angew. Chem. 2008, 120, 2874 –
2877.
[19] a) W. Siti, A. K. Khan, H.-P. M. de Hoog, B. Liedberg, M.
Nallani, Org. Biomol. Chem. 2015, 13, 3202 – 3206; b) Z. Li, L.
Qian, L. Li, J. C. Bernhammer, H. V. Huynh, J.-S. Lee, S. Q. Yao,
Angew. Chem. Int. Ed. 2016, 55, 2002 – 2006; Angew. Chem.
2016, 128, 2042 – 2046.
[20] a) L. Xue, I. A. Karpenko, J. Hiblot, K. Johnsson, Nat. Chem.
Biol. 2015, 11, 917 – 923; b) N. Krall, F. P. da Cruz, O. Boutureira,
G. J. L. Bernardes, Nat. Chem. 2016, 8, 103 – 113.
Received: August 29, 2016
Revised: September 27, 2016
Published online: October 20, 2016
Angewandte
ChemieCommunications
14687Angew. Chem. Int. Ed. 2016, 55, 14683 –14687 T 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
